1. Home
  2. PODD vs TXT Comparison

PODD vs TXT Comparison

Compare PODD & TXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • TXT
  • Stock Information
  • Founded
  • PODD 2000
  • TXT 1923
  • Country
  • PODD United States
  • TXT United States
  • Employees
  • PODD N/A
  • TXT N/A
  • Industry
  • PODD Medical/Dental Instruments
  • TXT Aerospace
  • Sector
  • PODD Health Care
  • TXT Industrials
  • Exchange
  • PODD Nasdaq
  • TXT Nasdaq
  • Market Cap
  • PODD 16.5B
  • TXT 15.2B
  • IPO Year
  • PODD 2007
  • TXT N/A
  • Fundamental
  • Price
  • PODD $260.12
  • TXT $85.19
  • Analyst Decision
  • PODD Buy
  • TXT Buy
  • Analyst Count
  • PODD 15
  • TXT 9
  • Target Price
  • PODD $251.53
  • TXT $101.56
  • AVG Volume (30 Days)
  • PODD 609.1K
  • TXT 1.3M
  • Earning Date
  • PODD 11-07-2024
  • TXT 10-24-2024
  • Dividend Yield
  • PODD N/A
  • TXT 0.09%
  • EPS Growth
  • PODD 235.68
  • TXT N/A
  • EPS
  • PODD 5.74
  • TXT 4.55
  • Revenue
  • PODD $1,983,900,000.00
  • TXT $13,981,000,000.00
  • Revenue This Year
  • PODD $22.33
  • TXT $2.33
  • Revenue Next Year
  • PODD $18.50
  • TXT $7.58
  • P/E Ratio
  • PODD $45.35
  • TXT $18.61
  • Revenue Growth
  • PODD 27.42
  • TXT 4.13
  • 52 Week Low
  • PODD $160.19
  • TXT $74.13
  • 52 Week High
  • PODD $279.40
  • TXT $97.34
  • Technical
  • Relative Strength Index (RSI)
  • PODD 63.27
  • TXT 52.27
  • Support Level
  • PODD $233.48
  • TXT $86.83
  • Resistance Level
  • PODD $276.57
  • TXT $89.28
  • Average True Range (ATR)
  • PODD 8.53
  • TXT 1.61
  • MACD
  • PODD 2.16
  • TXT 0.41
  • Stochastic Oscillator
  • PODD 63.19
  • TXT 70.44

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

About TXT Textron Inc.

Textron is a conglomerate that designs, manufactures, and services a range of specialty aircraft including small jets, propeller-driven airplanes, helicopters, and tilt-rotor aircraft. Textron Aviation manufactures and services Cessna and Beechcraft planes. Bell is a helicopter and tilt-rotor manufacturer and servicer for both commercial and military customers. Textron Systems produces uncrewed aircraft and armored vehicles for the military market as well as aircraft simulators and training for the commercial and military markets. Textron Industrial contains the Kautex business, which manufactures plastic fuel tanks for conventional and hybrid motor vehicles, and other subsidiaries that produce specialized vehicles such as golf carts, snowmobiles, and all-terrain vehicles.

Share on Social Networks: